HYVET

(redirected from Hypertension in the Very Elderly Trial)
AcronymDefinition
HYVETHypertension in the Very Elderly Trial
References in periodicals archive ?
No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the Hypertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over.
Treating hypertensive patients 80 and older could help lower their risk of cognitive decline, according to the results of an analysis of the Hypertension in the Very Elderly Trial (HYVET), published in the July 8 issue of The Lancet Neurology.
The results of the Hypertension in the Very Elderly Trial should change our practice, a change that can improve the quality of life while prolonging the survival of patients 80 years of age and older (N.
Launched in 2001, the double-blind, placebo-controlled study, known as the Hypertension in the Very Elderly Trial (HYVET), enrolled 3,845 patients with high blood pressure aged 80 and older.
Preliminary results from the Hypertension in the Very Elderly Trial (HYVET) suggest that trial participants, who were in their 80s, had a lower risk of dying when they were treated with antihypertensive medications.